Latest Deals - Pharmaceutical Technology
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

Marathon Asset Management has entered a definitive agreement to acquire US-based pharmaceutical firm Kaléo in a deal valued at $310m…

30 Nov 2021

Marathon Asset Management has entered a definitive agreement to acquire US-based pharmaceutical firm Kaléo in a deal valued at $310m in cash. The purchase value includes potential milestone payments based…

29 Nov 2021

Link Health Pharma has entered a non-binding term sheet to acquire worldwide rights for Bone Therapeutics’ allogeneic bone cell therapy, ALLOB. ALLOB contains human bone-forming cells obtained from adult donors’…

29 Nov 2021

Enzychem Lifesciences and Cadila Healthcare, a Zydus Group unit, have signed an agreement to manufacture the first-ever Covid-19 plasmid deoxyribonucleic acid (DNA) vaccine, ZyCoV-D. According to the manufacturing licence and…

26 Nov 2021

A consortium led by Icelandic pharmaceutical investment fund Aztiq and Thailand-based life sciences company Innobic has agreed to acquire all shares of Alvogen Emerging Market Holdings (AEMH) from its current…

25 Nov 2021

GreenLight Biosciences and Samsung Biologics have signed a collaboration agreement for manufacturing messenger ribonucleic acid (mRNA) Covid-19 vaccines. Under the terms of the agreement, Samsung Biologics will be responsible for…

23 Nov 2021

Twist Bioscience has signed a definitive agreement to acquire in vivo antibody discovery services firm Abveris for up to $190m to boost its biopharma expertise. Previously known as AbX Biologics,…